Control of MRSA infection and colonisation in an intensive care unit by GeneOhm MRSA assay and culture methods.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 2738678)

Published in BMC Infect Dis on August 24, 2009

Authors

Claudia Dalla Valle1, Maria Rosalia Pasca, Debora De Vitis, Federico Capra Marzani, Vincenzo Emmi, Piero Marone

Author Affiliations

1: Laboratorio di Batteriologia e Micologia, Area Infettivologica, Fondazione IRCCS S, Matteo, Pavia, Italia. claudia_dallavalle01@yahoo.it

Articles cited by this

The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis (2006) 4.60

Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis (2004) 4.17

Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol (2000) 3.82

Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol (2004) 3.18

Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect (2006) 3.14

Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 2.16

Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J Clin Microbiol (2006) 2.15

In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet (2001) 2.14

Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol (2007) 1.99

Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol (2007) 1.97

Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. J Clin Microbiol (2007) 1.79

Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens. Eur J Clin Microbiol Infect Dis (2007) 1.68

Comparison of BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR versus the CHROMagar MRSA assay for screening patients for the presence of MRSA strains. J Clin Microbiol (2007) 1.54

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis (2005) 1.45

MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. Eur J Clin Microbiol Infect Dis (2008) 1.04

Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles. Eur J Clin Microbiol Infect Dis (2007) 1.01

Prevention and control of methicillin-resistant Staphylococcus aureus. Dis Mon (2008) 0.86

The continuing saga of MRSA. J Infect Dis (2008) 0.82

One-year experience with modified BD GeneOhm MRSA assay for detection of methicillin-resistant Staphylococcus aureus from pooled nasal, skin, and throat samples. Diagn Microbiol Infect Dis (2008) 0.79

MRSA: an evolving pathogen. Dis Mon (2008) 0.78

Articles by these authors

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science (2009) 3.39

Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med (2012) 1.78

MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob Agents Chemother (2011) 1.51

Mycobacterium tuberculosis: drug resistance and future perspectives. Future Microbiol (2009) 1.29

Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol (2006) 1.26

Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb) (2008) 1.24

Management of splenic abscess: report on 16 cases from a single center. Int J Infect Dis (2008) 1.21

Paranasal sinus fungus ball: diagnosis and management. Mycoses (2007) 1.20

Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One (2011) 1.14

Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Mol Microbiol (2010) 1.12

Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses (2011) 1.11

The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. Appl Microbiol Biotechnol (2013) 1.04

Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS One (2011) 1.04

Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? Pathog Glob Health (2012) 0.96

Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLoS One (2013) 0.94

Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol (2004) 0.93

LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. Antimicrob Agents Chemother (2006) 0.88

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. PLoS One (2011) 0.86

Mycobacterium tuberculosis chaperonin 10 is secreted in the macrophage phagosome: is secretion due to dissociation and adoption of a partially helical structure at the membrane? J Bacteriol (2003) 0.86

Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin. Genome Announc (2013) 0.86

Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb Drug Resist (2011) 0.86

Exploring the HME and HAE1 efflux systems in the genus Burkholderia. BMC Evol Biol (2010) 0.85

Lyme borreliosis, Po River Valley, Italy. Emerg Infect Dis (2010) 0.85

Phenotypic and genotypic characterisation of Burkholderia cenocepacia J2315 mutants affected in homoserine lactone and diffusible signal factor-based quorum sensing systems suggests interplay between both types of systems. PLoS One (2013) 0.85

Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy. Genome Announc (2013) 0.84

Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. ACS Chem Biol (2014) 0.83

Genomic analysis of zinc homeostasis in Mycobacterium tuberculosis. FEMS Microbiol Lett (2008) 0.83

Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis. Eur J Med Chem (2013) 0.83

A census of RND superfamily proteins in the Burkholderia genus. Future Microbiol (2013) 0.82

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. J Med Chem (2014) 0.82

Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. Transplantation (2012) 0.81

Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. Res Microbiol (2005) 0.81

Draft Genome Sequence of Stenotrophomonas maltophilia Strain EPM1, Found in Association with a Culture of the Human Parasite Giardia duodenalis. Genome Announc (2013) 0.81

Retracted Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art. Appl Microbiol Biotechnol (2012) 0.79

Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test conversion after unprotected exposure to patients with pulmonary tuberculosis: 6-year experience in an Italian teaching hospital. BMC Infect Dis (2014) 0.78

Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents. Eur J Med Chem (2012) 0.78

Epidemiology of bacterial meningitis in Lombardy Region in the period 2000-2006. New Microbiol (2007) 0.77

Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis. Eur J Med Chem (2013) 0.77

Microarray technology for yeast identification directly from positive blood cultures. A multicenter Italian experience. Med Mycol (2012) 0.77

Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents. Eur J Med Chem (2011) 0.77

DprE1, a new taxonomic marker in mycobacteria. FEMS Microbiol Lett (2013) 0.76

Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion. New Microbiol (2012) 0.76

Bacterial genomic epidemiology, from local outbreak characterization to species-history reconstruction. Pathog Glob Health (2015) 0.75

Iron Acquisition Pathways as Targets for Antitubercular Drugs. Curr Med Chem (2016) 0.75

Mycobacterium avium paratuberculosis in Italy: commensal or emerging human pathogen? Dig Liver Dis (2012) 0.75

A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors. ACS Infect Dis (2017) 0.75

Antibacterial activity and cytotoxic effect of SIAB-GV3. New Microbiol (2014) 0.75